Related Experiment Video
Updated: Jul 30, 2026
14:21
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Buspirone: chemistry, pharmacology, and behavior
The Journal of Clinical Psychiatry
|December 1, 1982
Summary
Buspirone, a nonbenzodiazepine anxiolytic, may act independently of the GABA-benzodiazepine receptor complex. Its effects on anxiety might involve dopaminergic pathways and a distinct effector system, offering new insights into anxiolytic drug mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
- Anxiolytic Drug Action
Background:
- Buspirone is a nonbenzodiazepine anxiolytic with a distinct pharmacological profile.
- Its mechanism of action is not fully understood, particularly its relationship with the GABA-benzodiazepine receptor complex.
Purpose of the Study:
- To critically discuss the neurochemical and behavioral observations related to buspirone.
- To explore the role of the GABA-benzodiazepine receptor-chloride ionophore complex in buspirone's actions.
- To investigate the involvement of dopaminergic pathways in anxiety and anxiolytic effects.
- To examine the potential existence of a common effector system for buspirone and other antianxiety agents.
Main Methods:
- Critical discussion of recent neurochemical findings.
- Analysis of behavioral observations related to buspirone.
- Review of existing literature on anxiolytics and their mechanisms.
Main Results:
- Buspirone's actions may not solely depend on the GABA-benzodiazepine receptor-chloride ionophore complex.
- Dopaminergic pathways are implicated in anxiety modulation and/or anxiolytic effects.
- Evidence suggests a potential common effector system for buspirone and other antianxiety agents.
Conclusions:
- Buspirone likely represents a novel class of anxiolytic, potentially acting via non-GABA-benzodiazepine mechanisms.
- Dopamine system involvement offers new therapeutic targets for anxiety disorders.
- Further research is needed to fully elucidate the effector systems underlying buspirone's efficacy.
Related Concept Videos
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...